301293.SHE Sanbo Hospital Management Group Ltd. A
- Market cap
- CNY 9.93B
- P/E
- 146.1x
- P/B
- 4.25x
- ROE
- 3.7%
- Dividend yield
- 0.37%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 301293.SHE undervalued?
Graham numberThe Graham number of Sanbo Hospital Management Group Ltd. A cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Sanbo Hospital Management Group Ltd. A fundamental analysis
No fundamental analysis for Sanbo Hospital Management Group Ltd. A yet.
Sanbo Hospital Management Group Ltd. A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Sanbo Hospital Management Group Ltd. A
Sanbo Hospital Management Group Limited, together with its subsidiaries, engages in hospital management in China. The company operates neurology and general hospitals. It is also involved in clinical medical; medical device management; medical investment; and property management services. It also offers neurosurgery services, including brain tumor surgery, cerebral vascular bypass surgery, functional neurosurgery for epilepsy and Parkinson's disease, spinal cord and nerve su…
Full company profileSanbo Hospital Management Group Ltd. A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Sanbo Hospital Management Group Ltd. A annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 1.14B | 1.07B | 1.31B | 1.43B | 1.73B | 1.97B |
| Gross Profit | 275M | 233M | 294M | 336M | 402M | 444M |
| Operating Income | 127M | 97.2M | 133M | 144M | 149M | 172M |
| EBITDA | - | 193M | 205M | 236M | 243M | 144M |
| Net Income | 76.7M | 63.4M | 78.2M | 105M | 84.2M | 90.3M |
| EPS | 0.50 | 0.41 | 0.38 | 0.51 | 0.41 | 0.44 |
| Balance Sheet | ||||||
| Total Assets | 1.79B | 1.94B | 3.13B | 3.53B | 3.91B | 3.97B |
| Total Liabilities | 551M | 558M | 626M | 901M | 1.26B | 1.29B |
| Shareholders' Equity | 1.13B | 1.24B | 2.32B | 2.30B | 2.34B | 2.41B |
| Cash & Short-term Investments | 462M | 600M | 822M | 708M | 448M | 445M |
| Cash Flow | ||||||
| Operating Cash Flow | 122M | 153M | 246M | 162M | 188M | - |
| Capital Expenditure | 145M | 90.0M | 170M | 542M | 586M | 236M |
| Free Cash Flow | -23.1M | 63.0M | 76.0M | -380M | -398M | 40.3M |
| Ratios | ||||||
| ROE | 6.8% | 5.1% | 3.4% | 4.6% | 3.6% | 3.7% |
| ROA | 4.3% | 3.3% | 2.5% | 3.0% | 2.2% | 2.3% |
| Net Profit Margin | 6.7% | 5.9% | 6.0% | 7.3% | 4.9% | 4.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Sanbo Hospital Management Group Ltd. A dividends
- Dividend yield
- 0.37%
- Forward dividend
- -
- Payout ratio
- 43.4%
- Ex-dividend date
- Jul 9, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 36.5M | 0.18 | 43.4% |
| 2024 | CNY 15.1M | 0.07 | 14.3% |
| 2023 | CNY 554K | 0.00 | 0.7% |
| 2022 | CNY 527K | 0.00 | 0.8% |
| 2021 | CNY 952K | 0.01 | 1.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.3:1 on Jun 27, 2024.
Who owns Sanbo Hospital Management Group Ltd. A
- Insiders 37.39%
- Institutions 3.82%
- Public & others 58.79%
- Shares outstanding 206M
- Free float 158M
Sanbo Hospital Management Group Ltd. A company profile
- Company name
- Sanbo Hospital Management Group Ltd. A
- Ticker
- 301293.SHE
- ISIN
- CNE1000061W6
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 2,889
- Fiscal year end
- December
- Address
- Century Golden Resources Business Center, Building A, Beijing, China, 10009
- Phone
- 86 10 6288 2959
- Website
- sbnkjt.com
About Sanbo Hospital Management Group Ltd. A
Sanbo Hospital Management Group Limited, together with its subsidiaries, engages in hospital management in China. The company operates neurology and general hospitals. It is also involved in clinical medical; medical device management; medical investment; and property management services. It also offers neurosurgery services, including brain tumor surgery, cerebral vascular bypass surgery, functional neurosurgery for epilepsy and Parkinson's disease, spinal cord and nerve surgery, and pediatric neurosurgery; neurointervention; neuro-oncology chemotherapy and radiotherapy, including Gamma Knife and linear accelerator treatments; neurocritical care, and perioperative neurological monitoring. Sanbo Hospital Management Group Limited was founded in 2003 and is headquartered in Beijing, China.
Sanbo Hospital Management Group Ltd. A management
7- Mr. Xiangying XuGM & Non-Independent Director · born 1973
- Mr. Qiao MinghaoFinance Director · born 1982
- Mr. Binbin CaiDeputy GM & Non-Independent Director · born 1967
- Mr. Hu WeiweiDeputy GM & Secretary of the Board of Directors · born 1984
- Mr. Sun JirangDeputy General Manager · born 1967
- Mr. Lin ZhixiongDeputy General Manager · born 1967
- Jinling GaoAccounting Supervisor